Literature DB >> 4122312

Studies on the mechanism of antitumor effect of bleomycin of squamous cell carcinoma.

H Umezawa, T Takeuchi, S Hori, T Sawa, M Ishizuka.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4122312     DOI: 10.7164/antibiotics.25.409

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN: 0021-8820            Impact factor:   2.649


× No keyword cloud information.
  18 in total

Review 1.  Antitumor antibiotics discovered and studied at the Institute of Microbial Chemistry.

Authors:  T Takeuchi
Journal:  J Cancer Res Clin Oncol       Date:  1995       Impact factor: 4.553

2.  High-performance liquid chromatography assay of bleomycin in human plasma and rat hepatocytes in culture.

Authors:  R Mahdadi; A Kenani; N Pommery; J Pommery; J P Hénichart; M Lhermitte
Journal:  Cancer Chemother Pharmacol       Date:  1991       Impact factor: 3.333

Review 3.  Leukotriene receptors as potential therapeutic targets.

Authors:  Takehiko Yokomizo; Motonao Nakamura; Takao Shimizu
Journal:  J Clin Invest       Date:  2018-05-14       Impact factor: 14.808

4.  Bleomycin: action on growth of oncogenic RNA viruses and on cell transformation.

Authors: 
Journal:  Arch Virol       Date:  1975       Impact factor: 2.574

5.  Uptake of 67Ga-6-mercaptopurines in Morris hepatoma-3924 A.

Authors:  A Guarino; S K Shukla; L Castelli; C Cipriani; G B Manni
Journal:  Eur J Nucl Med       Date:  1979-06-01

6.  Design and Synthesis of Activity-Based Probes and Inhibitors for Bleomycin Hydrolase.

Authors:  Wouter A van der Linden; Ehud Segal; Matthew A Child; Anna Byzia; Marcin Drąg; Matthew Bogyo
Journal:  Chem Biol       Date:  2015-08-06

7.  Astrogliosis and behavioral changes in mice lacking the neutral cysteine protease bleomycin hydrolase.

Authors:  S E Montoya; E Thiels; J P Card; J S Lazo
Journal:  Neuroscience       Date:  2007-03-27       Impact factor: 3.590

8.  Lack of metabolism as the biochemical basis of bleomycin-induced pulmonary toxicity.

Authors:  J S Lazo; C J Humphreys
Journal:  Proc Natl Acad Sci U S A       Date:  1983-05       Impact factor: 11.205

9.  Therapy of solid Walker carcinosarcoma 256 with bleomycin after synchronization with hydroxyurea.

Authors:  M Volm; J Mattern; N Weber; K Wayss
Journal:  Cancer Chemother Pharmacol       Date:  1980       Impact factor: 3.333

10.  Hyperpigmentation after bleomycin therapy. Ultrastructural study.

Authors:  H Perrot; J P Ortonne
Journal:  Arch Dermatol Res       Date:  1978-05-31       Impact factor: 3.017

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.